Sentence examples for key pharmaceuticals from inspiring English sources

Took over Key Pharmaceuticals with partner Michael Jaharis (see), created new delivery systems for old drugs.

We thank Key Pharmaceuticals and Mentholatum for donating ovulation predictor kits and Bonds for donating singlets for the photographed males.

Each participant used an Ovuplan (Key Pharmaceuticals) or Confirm (Mentholatum) ovulation predictor kit that determines a surge in luteinizing hormone (LH): the hormone that triggers ovulation.

Randomised patients will receive either 2000IU oral cholecalciferol/day (two 25 μcg tablets, Ostevit-D, Key Pharmaceuticals Pty Limited, NSW) or two placebo tablets/day for a total duration of 6 months.

Universities have held US patent rights in a wide array of key pharmaceuticals, including the cancer drugs cisplatin and carboplatin, pemetrexed (Alimta), cetuximab (Erbitux); the anemia treatment epoetin alfa (Epogen); the AIDS drugs stavudine (Zerit), 3TC (Epivir), abacavir (Ziagen), and T20 (Fuzeon); and the best-selling glaucoma medicine latanoprost (Xalatan) [ 15].

The Physicians' Desk Reference (Thomson Healthcare 1995 2010a) contained some additional product labels, especially older versions of labels and discontinued products (e.g., Theo-Dur; Key Pharmaceuticals Inc., Kenilworth, NJ); however, available information was limited to manufacturers who elected to include their products in the reference.

(R -2-chloromandelic acid R -2-chloromandelicaR -2-chloromandelicdiacid

Prediction of key pharmaceutical properties has become increasingly important with the use of high throughput screening (HTS).

Key pharmaceutical, biotechnology, academic, and National Institutes of Health scientists presented overviews of their new agents and products in clinical development (representing the next generation of promising agents).

Herein, a series of pyridinium-tailored 5-trifluoromethylpyrazoles containing 1,3,4-oxadiazole moieties were constructed through coupling key pharmaceutical fragments of pyridinium, pyrazole, and 1,3,4-oxadiazole scaffolds in single molecular architecture.

Specifically, this review will include a landscape survey of the systems that have been studied, the manufacturing processes involved, stability through the manufacturing process, key pharmaceutical formulation parameters that impact stability of the encased proteins, and storage stability of the encapsulated proteins in these delivery systems.